Published in Dermatol Surg on June 01, 2008
Calcium hydroxylapatite: over a decade of clinical experience. J Clin Aesthet Dermatol (2015) 0.84
Body vectoring technique with Radiesse(®) for tightening of the abdomen, thighs, and brachial zone. Clin Cosmet Investig Dermatol (2015) 0.82
Volume correction in the aging hand: role of dermal fillers. Clin Cosmet Investig Dermatol (2016) 0.78
Radiesse(®): a novel rejuvenation treatment for the upper arms. Clin Cosmet Investig Dermatol (2015) 0.75
Complete biodegradable nature of calcium hydroxylapatite after injection for malar enhancement: an MRI study. Clin Cosmet Investig Dermatol (2015) 0.75
Microscopic and ultrastructural evidences in human skin following calcium hydroxylapatite filler treatment. Arch Dermatol Res (2017) 0.75
Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals. Hepatology (2013) 2.76
18 years of the Fontan operation at a single institution: results from 771 consecutive patients. J Am Coll Cardiol (2012) 2.24
Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland. Hepatology (2005) 1.91
Excess liver-related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from care. Hepatology (2011) 1.68
Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations. Hepatology (2011) 1.67
The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium. Pediatr Cardiol (2012) 1.62
Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis. Clin Infect Dis (2013) 1.61
High-fluence and high-density treatment of perioral rhytides using a new, fractionated 2,790-nm ablative erbium-doped Yttrium Scandium Gallium Garnet Laser. Dermatol Surg (2011) 1.60
Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis. Clin Gastroenterol Hepatol (2005) 1.53
Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility. J Hepatol (2011) 1.50
Outcomes of Single-Ventricle Patients Supported With Extracorporeal Membrane Oxygenation. Pediatr Crit Care Med (2016) 1.42
Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy. Clin Infect Dis (2013) 1.38
A multistep approach to improving biopsy site identification in dermatology: physician, staff, and patient roles based on a Delphi consensus. JAMA Dermatol (2014) 1.37
Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol (2013) 1.23
Portal and sinusoidal fibrosis are common on liver biopsy after Fontan surgery. Pediatr Cardiol (2012) 1.18
Association of self-reported alcohol use and hospitalization for an alcohol-related cause in Scotland: a record-linkage study of 23,183 individuals. Addiction (2009) 1.18
Nd:YAG laser (1064 nm) irradiation for lower extremity telangiectases and small reticular veins: efficacy as measured by vessel color and size. Dermatol Surg (2002) 1.17
A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg (2004) 1.07
The use of photodynamic therapy in dermatology: results of a consensus conference. J Drugs Dermatol (2006) 1.03
A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland. Stat Methods Med Res (2008) 1.03
Radiofrequency in cosmetic dermatology: a review. Dermatol Surg (2012) 1.00
Dermal fillers: complications and informed consent. J Cosmet Laser Ther (2005) 1.00
Topical anesthetics for cosmetic and laser dermatology. J Drugs Dermatol (2005) 0.99
Failure of the fontan circulation. Heart Fail Clin (2014) 0.99
Mesotherapy for facial skin rejuvenation: a clinical, histologic, and electron microscopic evaluation. Dermatol Surg (2006) 0.98
Clinical, histologic and electron microscopic findings after injection of a calcium hydroxylapatite filler. J Cosmet Laser Ther (2004) 0.98
Extraocular sebaceous carcinoma treated with Mohs micrographic surgery: report of a case and review of literature. Dermatol Surg (2007) 0.97
Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland. Int J Drug Policy (2012) 0.95
Detection of hepatitis C virus RNA in dried blood spots. J Clin Virol (2012) 0.94
Decrease in health-related quality of life associated with awareness of hepatitis C virus infection among people who inject drugs in Scotland. J Hepatol (2012) 0.94
Drug-related deaths by region, sex, and age group per 100 injecting drug users in Scotland, 2000-01. Lancet (2003) 0.93
Atrophic and a mixed pattern of acne scars improved with a 1320-nm Nd:YAG laser. Dermatol Surg (2003) 0.93
Anthrax infection among heroin users in Scotland during 2009-2010: a case-control study by linkage to a national drug treatment database. Clin Infect Dis (2012) 0.93
Laser lipolysis of the arm, with and without suction aspiration: clinical and histologic changes. J Cosmet Laser Ther (2009) 0.93
Infections with spore-forming bacteria in persons who inject drugs, 2000-2009. Emerg Infect Dis (2013) 0.93
Ultrastructural changes seen after ALA-IPL photorejuvenation: a pilot study. J Cosmet Laser Ther (2005) 0.92
How do centres begin the process to prevent contrast-induced acute kidney injury: a report from a new regional collaborative. BMJ Qual Saf (2011) 0.91
A prospective study of fractional scanned nonsequential carbon dioxide laser resurfacing: a clinical and histopathologic evaluation. Dermatol Surg (2009) 0.90
Clinical, histologic, and ultrastructural changes after use of human growth factor and cytokine skin cream for the treatment of skin rejuvenation. J Cosmet Laser Ther (2008) 0.90
Prevalence and determinants of hepatitis C virus infection among female drug injecting sex workers in Glasgow. Harm Reduct J (2008) 0.90
Ablative skin resurfacing. Curr Probl Dermatol (2011) 0.90
Complications from injectable polyacrylamide gel, a new nonbiodegradable soft tissue filler. Dermatol Surg (2004) 0.90
Clinical comparison of four hair removal lasers and light sources. J Cosmet Laser Ther (2006) 0.90
Safety and efficacy of intradermal injection of botulinum toxin for the treatment of oily skin. Dermatol Surg (2013) 0.89
Use of phosphatidylcholine for the correction of lower lid bulging due to prominent fat pads. J Cosmet Laser Ther (2006) 0.89
Vascular-specific laser wavelength for the treatment of facial telangiectasias. J Drugs Dermatol (2009) 0.89
Calcium hydroxylapatite for facial rejuvenation. Semin Cutan Med Surg (2006) 0.87
Radiofrequency in Cosmetic Dermatology: An Update. J Drugs Dermatol (2015) 0.87
The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatment. J Drugs Dermatol (2009) 0.86
Supplemental tube feeding does not mitigate weight loss in infants with shunt-dependent single-ventricle physiology. Pediatr Cardiol (2013) 0.86
Recent advances in laser dermatology. J Cosmet Laser Ther (2009) 0.86
308-nm Excimer laser treatment of mature hypopigmented striae. Dermatol Surg (2003) 0.85
Prevalence of deficient retro-aortic rim and its effects on outcomes in device closure of atrial septal defects. Pediatr Cardiol (2014) 0.85
Nonablative facial remodeling: erythema reduction and histologic evidence of new collagen formation using a 300-microsecond 1064-nm Nd:YAG laser. Arch Dermatol (2004) 0.85
Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in Scotland. Eur J Gastroenterol Hepatol (2012) 0.84
A review of sutures and other skin closure materials. J Cosmet Laser Ther (2010) 0.84
Assessment of safety and efficacy of a bipolar fractionated radiofrequency device in the treatment of photodamaged skin. J Cosmet Laser Ther (2012) 0.83
Treatment of melasma with low fluence, large spot size, 1064-nm Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser for the treatment of melasma in Fitzpatrick skin types II-IV. J Cosmet Laser Ther (2011) 0.83
Controlled volumetric heating of subcutaneous adipose tissue using a novel radiofrequency technology. Lasers Surg Med (2009) 0.83
Trends in the incidence of HIV in Scotland, 1988-2009. Sex Transm Infect (2011) 0.83
Sudden rise in uptake of hepatitis B vaccination among injecting drug users associated with a universal vaccine programme in prisons. Vaccine (2004) 0.82
Evaluation of a new super-long-pulsed 810 nm diode laser for the removal of unwanted hair: the concept of thermal damage time. Dermatol Surg (2002) 0.82
Electrosurgical resurfacing: a clinical, histologic, and electron microscopic evaluation. Lasers Surg Med (2003) 0.82
Millisecond 1064-nm neodymium:YAG laser treatment of facial telangiectases. Dermatol Surg (2003) 0.82
Laser hair removal pearls. J Cosmet Laser Ther (2008) 0.81
Digital photography, confidentiality, and teledermatology. Arch Dermatol (2004) 0.81
Suture material in cosmetic cutaneous surgery. J Cosmet Laser Ther (2007) 0.81
Safety and efficacy of fractional bipolar radiofrequency treatment in Fitzpatrick skin types V-VI. J Cosmet Laser Ther (2012) 0.80
Novel hyaluronic acid dermal filler: dermal gel extra physical properties and clinical outcomes. Dermatol Surg (2010) 0.80
Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation. Ann Thorac Surg (2010) 0.80
Multicenter study comparing shunt type in the norwood procedure for single-ventricle lesions: three-dimensional echocardiographic analysis. Circ Cardiovasc Imaging (2013) 0.80
Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost-effectiveness. Hepatology (2013) 0.79
Nonablative dermal remodeling: does it really work? Arch Dermatol (2002) 0.79
Energy-Based Devices in Treatment of Acne Vulgaris. Dermatol Surg (2016) 0.79
A hepatitis C avidity test for determining recent and past infections in both plasma and dried blood spots. J Clin Virol (2013) 0.79
Benign pigmented lesions. Curr Probl Dermatol (2011) 0.79
Hospitalisation for an alcohol-related cause among injecting drug users in Scotland: increased risk following diagnosis with hepatitis C infection. Int J Drug Policy (2010) 0.79
Review and meta-analysis of the association between self-reported sharing of needles/syringes and hepatitis C virus prevalence and incidence among people who inject drugs in Europe. Int J Drug Policy (2012) 0.78
Hospitalization of hepatitis C-diagnosed individuals in Scotland for decompensated cirrhosis: a population-based record-linkage study. Eur J Gastroenterol Hepatol (2010) 0.78
The prevalence of hepatitis C virus among people of South Asian origin in Glasgow - results from a community based survey and laboratory surveillance. Travel Med Infect Dis (2013) 0.78
Superficial erbium:YAG laser resurfacing of photodamaged skin. J Cosmet Laser Ther (2006) 0.78
The association between alcohol use and hepatitis C status among injecting drug users in Glasgow. Drug Alcohol Depend (2011) 0.78
Examination of the risk of reinfection with hepatitis C among injecting drug users who have been tested in Glasgow. Int J Drug Policy (2012) 0.78
Intense pulsed light: what works, what's new, what's next. Facial Plast Surg (2009) 0.78
Evaluation of histologic and electron microscopic changes after novel treatment using combined microdermabrasion and ultrasound-induced phonophoresis of human skin. J Cosmet Laser Ther (2008) 0.78
Non-ablative lasers. Curr Probl Dermatol (2011) 0.78
Fractional ablative laser skin resurfacing: a review. J Cosmet Laser Ther (2011) 0.77
Botulinum B treatment of the glabellar and frontalis regions: a dose response analysis. J Cosmet Laser Ther (2002) 0.77
Brain-type natriuretic peptide correlates with right heart pressures in a cross section of pediatric heart transplant patients. Pediatr Transplant (2010) 0.77
Patient compliance as a major determinant of laser tattoo removal success rates: a 10-year retrospective study. J Cosmet Laser Ther (2010) 0.77
A split-face comparison of two ablative fractional carbon dioxide lasers for the treatment of photodamaged facial skin. Dermatol Surg (2011) 0.77
Cutaneous photoaging treated with a combined 595/1064 nm laser. J Cosmet Laser Ther (2007) 0.77
Impact of intradermal abobotulinumtoxinA on facial erythema of rosacea. Dermatol Surg (2015) 0.76
Laser-assisted hair removal in Asian skin: efficacy, complications, and the effect of single versus multiple treatments. Dermatol Surg (2003) 0.76
Review of models used to predict the future numbers of individuals with severe hepatitis C disease: therapeutic and cost implications. Expert Rev Pharmacoecon Outcomes Res (2006) 0.76
Evaluation of clinical, microscopic, and ultrastructural changes after treatment with a novel Q-switched Nd:YAG laser. J Cosmet Laser Ther (2008) 0.76
Laser treatment of facial telangiectases: an update. Dermatol Surg (2010) 0.75
Evaluation of a long-pulsed Nd:YAG laser at different parameters: an analysis of both fluence and pulse duration. Dermatol Surg (2002) 0.75
HPV vaccine: positive insights from universal adolescent HepB vaccination. J Epidemiol Community Health (2007) 0.75
The value of genitourinary medicine clinics in the recognition and diagnosis of new cases of hepatitis C in the United Kingdom. Int J STD AIDS (2002) 0.75